Compare IRTC & LAZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IRTC | LAZ |
|---|---|---|
| Founded | 2006 | 1848 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 4.4B |
| IPO Year | 2016 | 2004 |
| Metric | IRTC | LAZ |
|---|---|---|
| Price | $110.69 | $36.76 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 13 | 8 |
| Target Price | ★ $197.92 | $52.75 |
| AVG Volume (30 Days) | 495.2K | ★ 1.3M |
| Earning Date | 04-30-2026 | 05-01-2026 |
| Dividend Yield | N/A | ★ 4.21% |
| EPS Growth | ★ 61.71 | N/A |
| EPS | N/A | ★ 0.91 |
| Revenue | $747,138,000.00 | ★ $3,186,466,000.00 |
| Revenue This Year | $19.60 | $13.36 |
| Revenue Next Year | $15.94 | $13.72 |
| P/E Ratio | ★ N/A | $39.69 |
| Revenue Growth | ★ 26.24 | 1.48 |
| 52 Week Low | $100.85 | $35.16 |
| 52 Week High | $210.01 | $58.75 |
| Indicator | IRTC | LAZ |
|---|---|---|
| Relative Strength Index (RSI) | 38.78 | 34.18 |
| Support Level | $102.62 | $35.16 |
| Resistance Level | $125.38 | $45.71 |
| Average True Range (ATR) | 4.19 | 1.90 |
| MACD | -0.51 | -0.36 |
| Stochastic Oscillator | 12.74 | 12.72 |
iRhythm Holdings Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
Lazard Inc is a financial advisory and asset management firm with operations in North and South America, Europe, the Middle East, Asia, and Australia. Lazard provides advice on mergers and acquisitions, capital markets and capital solutions, restructuring and liability management, geopolitics, and other strategic matters, as well as asset management and investment solutions to institutions, corporations, governments, partnerships, family offices, and high net worth individuals. Geographically, the company earns key revenue in the Americas, EMEA then Asia-Pacific.